OF CGNITIVE IMPAIRMENT
Cognitive disorders involve disturbances in information processing and integration associated with cognitive impairment and/or progressive cognitive decline. These disorders can be studied using translational EEG biomarkers that represent powerful assets to assess procognitive or anti-psychotic treatments efficacy.
Markers: ERPs, EROs, MMN, Gating, Multisite Coherence
Programs: Lead selection (screening of small libraries of compounds), lead validation (dose-response effect, pharmacokinetic), rodent model phenotyping